You are here

Research

Discovery research at Simmons Cancer Institute (SCI) provides the novel findings in cancer biology which will translate to better detection, treatment, and prevention options in the future. Research efforts at SCI are revealing fresh aspects in cellular and molecular mechanisms promoting tumor growth and metastases, new biomarkers for earlier detection and monitoring of therapeutic interventions, innovative agents and approaches for the treatment and prevention of cancer growth and proliferation. Members of SCI performing these discovery-based efforts include:

  • Amy Arai, PhD (molecular oncology)
  • Sukesh Bhaumik, PhD (molecular oncology)
  • Laurent Brard, MD, PhD (gynecologic oncology)
  • Andrea Braundmeier-Fleming, PhD (gynecologic oncology, immuno-oncology)
  • Deliang Cao, PhD (inflammation and oncology)
  • Judy Davie, PhD
  • Meghna Desai, MD (hematology/oncology)
  • Danuta Dynda, MD (urological oncology)
  • Randolph Elble, PhD (cancer biology, tumor suppressors)
  • Keith Gagnon, PhD (molecular oncology)
  • Sabha Ganai, MD, PhD
  • Dale "Buck" Hales, PhD (ovarian cancer)
  • Kanako Hayashi, PhD (molecular oncology)
  • Wiley Jenkins, PhD (cancer disparities)
  • Farid Kadyrov, PhD (molecular oncology)
  • Aziz Khan, MD (clinical oncology research)
  • James MacLean II, PhD (molecular oncology)
  • Daotai Nie, PhD (molecular oncology, immuno-oncology)
  • Vickram Ramkumar, PhD (cell signaling in cancer)
  • Sophia Ran, PhD (breast cancer, immuno-oncology)
  • Krishna Rao, MD, PhD (clinical oncology, molecular oncology)
  • Sherjeel Sana, MD (clinical oncology)
  • Assaad Semaan, MD (gynecologic oncology)
  • Bradley Schwartz, MD (urologic oncology)
  • Stephen Stone, MD (melanoma prevention)
  • Donald Torry, PhD (immunology of cancer)
  • Andrew Wilber, PhD (cell biology and immunology of cancer)
  • Rong Yuan, MD, PhD (cell biology of cancer)